![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:EIF2AK3-MBD2 (FusionGDB2 ID:HG9451TG8932) |
Fusion Gene Summary for EIF2AK3-MBD2 |
![]() |
Fusion gene information | Fusion gene name: EIF2AK3-MBD2 | Fusion gene ID: hg9451tg8932 | Hgene | Tgene | Gene symbol | EIF2AK3 | MBD2 | Gene ID | 9451 | 8932 |
Gene name | eukaryotic translation initiation factor 2 alpha kinase 3 | methyl-CpG binding domain protein 2 | |
Synonyms | PEK|PERK|WRS | DMTase|NY-CO-41 | |
Cytomap | ('EIF2AK3')('MBD2') 2p11.2 | 18q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | eukaryotic translation initiation factor 2-alpha kinase 3PRKR-like endoplasmic reticulum kinasepancreatic EIF2-alpha kinasetruncated eukaryotic translation initiation factor 2 alpha kinase 3 | methyl-CpG-binding domain protein 2demethylase | |
Modification date | 20200320 | 20200313 | |
UniProtAcc | . | Q9UBB5 | |
Ensembl transtripts involved in fusion gene | ENST00000303236, ENST00000419748, ENST00000470706, | ||
Fusion gene scores | * DoF score | 6 X 7 X 4=168 | 13 X 7 X 7=637 |
# samples | 7 | 15 | |
** MAII score | log2(7/168*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(15/637*10)=-2.08633087176042 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: EIF2AK3 [Title/Abstract] AND MBD2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | EIF2AK3(88913241)-MBD2(51715381), # samples:1 EIF2AK3(88913242)-MBD2(51715381), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | EIF2AK3-MBD2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EIF2AK3-MBD2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. EIF2AK3-MBD2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. EIF2AK3-MBD2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | EIF2AK3 | GO:0006983 | ER overload response | 10677345|11907036 |
Hgene | EIF2AK3 | GO:0030968 | endoplasmic reticulum unfolded protein response | 10677345|11907036|22169477 |
Hgene | EIF2AK3 | GO:0046777 | protein autophosphorylation | 10026192|11907036 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-8080-01A | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
ChimerDB4 | STAD | TCGA-BR-8080 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
Top |
Fusion Gene ORF analysis for EIF2AK3-MBD2 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000303236 | ENST00000398398 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5CDS-intron | ENST00000303236 | ENST00000398398 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
5CDS-intron | ENST00000303236 | ENST00000579025 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5CDS-intron | ENST00000303236 | ENST00000579025 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
5CDS-intron | ENST00000303236 | ENST00000583046 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5CDS-intron | ENST00000303236 | ENST00000583046 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
5UTR-3CDS | ENST00000419748 | ENST00000256429 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5UTR-3CDS | ENST00000419748 | ENST00000256429 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
5UTR-intron | ENST00000419748 | ENST00000398398 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5UTR-intron | ENST00000419748 | ENST00000398398 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
5UTR-intron | ENST00000419748 | ENST00000579025 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5UTR-intron | ENST00000419748 | ENST00000579025 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
5UTR-intron | ENST00000419748 | ENST00000583046 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
5UTR-intron | ENST00000419748 | ENST00000583046 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
In-frame | ENST00000303236 | ENST00000256429 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
In-frame | ENST00000303236 | ENST00000256429 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
intron-3CDS | ENST00000470706 | ENST00000256429 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
intron-3CDS | ENST00000470706 | ENST00000256429 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
intron-intron | ENST00000470706 | ENST00000398398 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
intron-intron | ENST00000470706 | ENST00000398398 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
intron-intron | ENST00000470706 | ENST00000579025 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
intron-intron | ENST00000470706 | ENST00000579025 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
intron-intron | ENST00000470706 | ENST00000583046 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - |
intron-intron | ENST00000470706 | ENST00000583046 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000303236 | EIF2AK3 | chr2 | 88913241 | - | ENST00000256429 | MBD2 | chr18 | 51715381 | - | 3889 | 740 | 227 | 1273 | 348 |
ENST00000303236 | EIF2AK3 | chr2 | 88913242 | - | ENST00000256429 | MBD2 | chr18 | 51715381 | - | 3889 | 740 | 227 | 1273 | 348 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000303236 | ENST00000256429 | EIF2AK3 | chr2 | 88913241 | - | MBD2 | chr18 | 51715381 | - | 0.000276105 | 0.99972385 |
ENST00000303236 | ENST00000256429 | EIF2AK3 | chr2 | 88913242 | - | MBD2 | chr18 | 51715381 | - | 0.000276105 | 0.99972385 |
Top |
Fusion Genomic Features for EIF2AK3-MBD2 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
![]() |
![]() |
Top |
Fusion Protein Features for EIF2AK3-MBD2 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:88913241/chr18:51715381) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | MBD2 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binds hemimethylated DNA as well. Recruits histone deacetylases and DNA methyltransferases. Acts as transcriptional repressor and plays a role in gene silencing. Functions as a scaffold protein, targeting GATAD2A and GATAD2B to chromatin to promote repression. May enhance the activation of some unmethylated cAMP-responsive promoters. {ECO:0000269|PubMed:10471499, ECO:0000269|PubMed:10947852, ECO:0000269|PubMed:12665568, ECO:0000269|PubMed:16415179, ECO:0000269|PubMed:24307175, ECO:0000269|PubMed:9774669}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EIF2AK3 | chr2:88913241 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 49_52 | 146 | 1117.0 | Compositional bias | Note=Poly-Ala |
Hgene | EIF2AK3 | chr2:88913242 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 49_52 | 146 | 1117.0 | Compositional bias | Note=Poly-Ala |
Tgene | MBD2 | chr2:88913241 | chr18:51715381 | ENST00000583046 | 0 | 3 | 50_96 | 0 | 303.0 | Compositional bias | Note=Arg-rich | |
Tgene | MBD2 | chr2:88913241 | chr18:51715381 | ENST00000583046 | 0 | 3 | 6_140 | 0 | 303.0 | Compositional bias | Note=Gly-rich | |
Tgene | MBD2 | chr2:88913242 | chr18:51715381 | ENST00000583046 | 0 | 3 | 50_96 | 0 | 303.0 | Compositional bias | Note=Arg-rich | |
Tgene | MBD2 | chr2:88913242 | chr18:51715381 | ENST00000583046 | 0 | 3 | 6_140 | 0 | 303.0 | Compositional bias | Note=Gly-rich | |
Tgene | MBD2 | chr2:88913241 | chr18:51715381 | ENST00000583046 | 0 | 3 | 145_213 | 0 | 303.0 | Domain | MBD | |
Tgene | MBD2 | chr2:88913242 | chr18:51715381 | ENST00000583046 | 0 | 3 | 145_213 | 0 | 303.0 | Domain | MBD |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | EIF2AK3 | chr2:88913241 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 593_1077 | 146 | 1117.0 | Domain | Protein kinase |
Hgene | EIF2AK3 | chr2:88913242 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 593_1077 | 146 | 1117.0 | Domain | Protein kinase |
Hgene | EIF2AK3 | chr2:88913241 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 599_607 | 146 | 1117.0 | Nucleotide binding | ATP |
Hgene | EIF2AK3 | chr2:88913242 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 599_607 | 146 | 1117.0 | Nucleotide binding | ATP |
Hgene | EIF2AK3 | chr2:88913241 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 30_514 | 146 | 1117.0 | Topological domain | Lumenal |
Hgene | EIF2AK3 | chr2:88913241 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 536_1116 | 146 | 1117.0 | Topological domain | Cytoplasmic |
Hgene | EIF2AK3 | chr2:88913242 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 30_514 | 146 | 1117.0 | Topological domain | Lumenal |
Hgene | EIF2AK3 | chr2:88913242 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 536_1116 | 146 | 1117.0 | Topological domain | Cytoplasmic |
Hgene | EIF2AK3 | chr2:88913241 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 515_535 | 146 | 1117.0 | Transmembrane | Helical |
Hgene | EIF2AK3 | chr2:88913242 | chr18:51715381 | ENST00000303236 | - | 2 | 17 | 515_535 | 146 | 1117.0 | Transmembrane | Helical |
Tgene | MBD2 | chr2:88913241 | chr18:51715381 | ENST00000256429 | 1 | 7 | 50_96 | 234 | 1015.6666666666666 | Compositional bias | Note=Arg-rich | |
Tgene | MBD2 | chr2:88913241 | chr18:51715381 | ENST00000256429 | 1 | 7 | 6_140 | 234 | 1015.6666666666666 | Compositional bias | Note=Gly-rich | |
Tgene | MBD2 | chr2:88913242 | chr18:51715381 | ENST00000256429 | 1 | 7 | 50_96 | 234 | 1015.6666666666666 | Compositional bias | Note=Arg-rich | |
Tgene | MBD2 | chr2:88913242 | chr18:51715381 | ENST00000256429 | 1 | 7 | 6_140 | 234 | 1015.6666666666666 | Compositional bias | Note=Gly-rich | |
Tgene | MBD2 | chr2:88913241 | chr18:51715381 | ENST00000256429 | 1 | 7 | 145_213 | 234 | 1015.6666666666666 | Domain | MBD | |
Tgene | MBD2 | chr2:88913242 | chr18:51715381 | ENST00000256429 | 1 | 7 | 145_213 | 234 | 1015.6666666666666 | Domain | MBD |
Top |
Fusion Gene Sequence for EIF2AK3-MBD2 |
![]() |
>25669_25669_1_EIF2AK3-MBD2_EIF2AK3_chr2_88913241_ENST00000303236_MBD2_chr18_51715381_ENST00000256429_length(transcript)=3889nt_BP=740nt GGAAAGTCCACCTTCCCCAACAAGGCCAGCCTGGGAACATGGAGTGGCAGCGGCCGCAGCCAATGAGAGAGCAAACGCGCGGAAAGTTTG CTCAATGGGCGATGTCCGAGATAGGCTGTCACTCAGGTGGCAGCGGCAGAGGCCGGGCTGAGACGTGGCCAGGGGAACACGGCTGGCTGT CCAGGCCGTCGGGGCGGCAGTAGGGTCCCTAGCACGTCCTTGCCTTCTTGGGAGCTCCAAGCGGCGGGAGAGGCAGGCGTCAGTGGCTGC GCCTCCATGCCTGCGCGCGGGGCGGGACGCTGATGGAGCGCGCCATCAGCCCGGGGCTGCTGGTACGGGCGCTGCTGCTGCTGCTGCTGC TGCTGGGGCTCGCGGCAAGGACGGTGGCCGCGGGGCGCGCCCGTGGCCTCCCAGCGCCGACGGCGGAGGCGGCGTTCGGCCTCGGGGCGG CCGCTGCTCCCACCTCAGCGACGCGAGTACCGGCGGCGGGCGCCGTGGCTGCGGCCGAGGTGACTGTGGAGGACGCTGAGGCGCTGCCGG CAGCCGCGGGAGAGCAGGAGCCTCGGGGTCCGGAACCAGACGATGAGACAGAGTTGCGACCGCGCGGCAGGTCATTAGTAATTATCAGCA CTTTAGATGGGAGAATTGCTGCCTTGGATCCTGAAAATCATGGTAAAAAGCAGTGGGATTTGGATGTGGGATCCGGTTCCTTGGTGTCAT CCAGCCTTAGCAAACCAGAGGGTAAACCAGACTTGAATACAACATTGCCAATTAGACAAACAGCATCAATTTTCAAACAACCGGTAACCA AAGTCACAAATCATCCTAGTAATAAAGTGAAATCAGACCCACAACGAATGAATGAACAGCCACGTCAGCTTTTCTGGGAGAAGAGGCTAC AAGGACTTAGTGCATCAGATGTAACAGAACAAATTATAAAAACCATGGAACTACCCAAAGGTCTTCAAGGAGTTGGTCCAGGTAGCAATG ATGAGACCCTTTTATCTGCTGTTGCCAGTGCTTTGCACACAAGCTCTGCGCCAATCACAGGGCAAGTCTCCGCTGCTGTGGAAAAGAACC CTGCTGTTTGGCTTAACACATCTCAACCCCTCTGCAAAGCTTTTATTGTCACAGATGAAGACATCAGGAAACAGGAAGAGCGAGTACAGC AAGTACGCAAGAAATTGGAAGAAGCACTGATGGCAGACATCTTGTCGCGAGCTGCTGATACAGAAGAGATGGATATTGAAATGGACAGTG GAGATGAAGCCTAAGAATATGATCAGGTAACTTTCGACCGACTTTCCCCAAGAGAAAATTCCTAGAAATTGAACAAAAATGTTTCCACTG GCTTTTGCCTGTAAGAAAAAAAATGTACCCGAGCACATAGAGCTTTTTAATAGCACTAACCAATGCCTTTTTAGATGTATTTTTGATGTA TATATCTATTATTCAAAAAATCATGTTTATTTTGAGTCCTAGGACTTAAAATTAGTCTTTTGTAATATCAAGCAGGACCCTAAGATGAAG CTGAGCTTTTGATGCCAGGTGCAATCTACTGGAAATGTAGCACTTACGTAAAACATTTGTTTCCCCCACAGTTTTAATAAGAACAGATCA GGAATTCTAAATAAATTTCCCAGTTAAAGATTATTGTGACTTCACTGTATATAAACATATTTTTATACTTTATTGAAAGGGGACACCTGT ACATTCTTCCATCATCACTGTAAAGACAAATAAATGATTATATTCACAGACTGATTGGAATTCTTTCTGTTGAAAAGCACACACAATAAA GAACCCCTCGTTAGCCTTCCTCTGATTTACATTCAACTCTGATCCCTGGGCCTTAGGTTTGACATGGAGGTGGAGGAAGATAGCGCATAT ATTTGCAGTATGAACTATTGCCTCTGGACGTTGTGAGAATTGTGCTTTCACCAGAATTTCTAAGAATTTCTGCTAAATATCACCTAGCAT GTGTAATTTTTTTTCCTTGCCTGTGACTTGGACTTTTGATAGTTCTATAAGAATAAGGCTTTTTCTTCCCTTGGGCATGAGTCAGATACA CAAGGACCCTTCAGGTGTTACTAGAAGGCGTCCATGTTTATTGTTTTTTAAAGAATGTTTGGCACTCTCTAACGTCCACTAGCTTACTGA GTTATCAGGTGCAGGTCAGACTCTTGGCTACAGTGAGAGGCAGCTTCTAGACAGAGTTGCTTAATGAAAGGGTTTGTAATACTTTACAAA CCATTACCTGTACCTGGCCTGGCCTCCAAAATATTAACATTCTTTTTCTGTTGAAACTCGCGAGTGTAACTTTCATACCACTTGAATTTA TTGATATTTAATTATGAAAACTAGCATTACATTATTAAACGATTTCTAAAATCAAAACATACTTAATCTGATACCAAGGAAGGGAGGGAG TGGTTATAAGCAAATGAAAACAAATTTTGAGAGACAGAGCAAAAGTAAAATCATTCTATAGAAAAGGTGTGTTTATTTCTTAACTCTTGA GTTCTTTTAAAATTAGAACCTAAATGATGCAGTCAGGGGTATGACCAATTCCACATGAGTGTCACCTGTACATTTTATTACCACTACCTC CAGTTTCCAAGGCAGGGAAGAAGAGGGGAATAGTCAAAGCAATATGACTAGCTAGGTTTGGGCTGCTGTTTGGGCTGCTGTTTTTCCTGG ACTTTTATGCCAAACTACATAAATACTTCTTGGAATTCCTGATTTACGCTCAACTTTGATCCCTGGACCCTAGGGCCATTAGTTTCCTTG AAGCAGTCCTGCTGGTGGATGAGCAGGGAAACTTGTAGACCCTGGGAAGCCAATTGGTAGAGGGTGCCTGCCCGCCCCATCAGACTGTCC CAACTGGGGTGGGGGTGAGGATCATAGTGATTTCTTTTTAAAAGCTAGTATGACTAGTGAGAATGGATGTCCAAGGGCTTTTCTCTTCCT CCCCCGAGTCCACGATTCTTCATTTGTGATCAGGGTTGGGGTAACTTCACCTTGGTGATCATATATTCTTTTTACAAACCAATCCAGCCA AGATATATGTGCTTTTCTAAACAGCTTGTAAAAGCAAAAACACAATGTATACACATATAAAACTGATTTTTTTTTTTTTGCTTATATACT TTGCTCAGGTGGAGAACAAGGTATGAAAGCCATTATATGGTGTCCCTTGGGGACCATCCCATAAGTCCAGGGTGTTCCCAATATACCCAC AAGACAACATGTTCAAAACTTCATCACCTGGTCCCCACAAACCTACCACCCTCTTCCATTCCCTCACTCTGGTAAAAGCAAGCCATCTTC TCCAGTTACGCAAGGCAGAAGCCCAGGAGTGAGCACAATGCTGCCCTTTCCCTTGCTTCTGACTTCTCATCAATCCTATTAGAACTACTG ACTGCACCCCACCTCTCCTCCATCCCCACGATCACTGCCTTCATATGAACTGCCTTTCCTGTCCTCTGGACTTTCAGTGGCTTCCTTTTT TGCTCACCTGTCCACTTTCTTCCCCTTCCCTCTCTCCATCCCTCCACATAGTCATCAGAAAGATCATCAAAACAGGCAAATGTGACTGTA TTATTTCCCTCACTTATCTTTGTATGCAGTTTAGAGTGATTTTTAAGAGCACACACTTTGAAATTAGGAGAACCTGTGTCTGAATCCTGA TTTTTGCCATTTGTGTGACTTGTCAGGTTATTTAATCTCTTTGAGCCTGTCCCTCCTCAGTGAAATAGGAATAATAATACCTACCTCATA GAGTTGTTGTGAGGATTCAGTGAGATAGACTGTTTCTAAAGTGTGTAGCACAGTGCCTGGCACATAGTGGGTGCTCACATTGGAGCACAC TATTGTCGCTATCCCTGCA >25669_25669_1_EIF2AK3-MBD2_EIF2AK3_chr2_88913241_ENST00000303236_MBD2_chr18_51715381_ENST00000256429_length(amino acids)=348AA_BP=171 MGAPSGGRGRRQWLRLHACARGGTLMERAISPGLLVRALLLLLLLLGLAARTVAAGRARGLPAPTAEAAFGLGAAAAPTSATRVPAAGAV AAAEVTVEDAEALPAAAGEQEPRGPEPDDETELRPRGRSLVIISTLDGRIAALDPENHGKKQWDLDVGSGSLVSSSLSKPEGKPDLNTTL PIRQTASIFKQPVTKVTNHPSNKVKSDPQRMNEQPRQLFWEKRLQGLSASDVTEQIIKTMELPKGLQGVGPGSNDETLLSAVASALHTSS APITGQVSAAVEKNPAVWLNTSQPLCKAFIVTDEDIRKQEERVQQVRKKLEEALMADILSRAADTEEMDIEMDSGDEA -------------------------------------------------------------- >25669_25669_2_EIF2AK3-MBD2_EIF2AK3_chr2_88913242_ENST00000303236_MBD2_chr18_51715381_ENST00000256429_length(transcript)=3889nt_BP=740nt GGAAAGTCCACCTTCCCCAACAAGGCCAGCCTGGGAACATGGAGTGGCAGCGGCCGCAGCCAATGAGAGAGCAAACGCGCGGAAAGTTTG CTCAATGGGCGATGTCCGAGATAGGCTGTCACTCAGGTGGCAGCGGCAGAGGCCGGGCTGAGACGTGGCCAGGGGAACACGGCTGGCTGT CCAGGCCGTCGGGGCGGCAGTAGGGTCCCTAGCACGTCCTTGCCTTCTTGGGAGCTCCAAGCGGCGGGAGAGGCAGGCGTCAGTGGCTGC GCCTCCATGCCTGCGCGCGGGGCGGGACGCTGATGGAGCGCGCCATCAGCCCGGGGCTGCTGGTACGGGCGCTGCTGCTGCTGCTGCTGC TGCTGGGGCTCGCGGCAAGGACGGTGGCCGCGGGGCGCGCCCGTGGCCTCCCAGCGCCGACGGCGGAGGCGGCGTTCGGCCTCGGGGCGG CCGCTGCTCCCACCTCAGCGACGCGAGTACCGGCGGCGGGCGCCGTGGCTGCGGCCGAGGTGACTGTGGAGGACGCTGAGGCGCTGCCGG CAGCCGCGGGAGAGCAGGAGCCTCGGGGTCCGGAACCAGACGATGAGACAGAGTTGCGACCGCGCGGCAGGTCATTAGTAATTATCAGCA CTTTAGATGGGAGAATTGCTGCCTTGGATCCTGAAAATCATGGTAAAAAGCAGTGGGATTTGGATGTGGGATCCGGTTCCTTGGTGTCAT CCAGCCTTAGCAAACCAGAGGGTAAACCAGACTTGAATACAACATTGCCAATTAGACAAACAGCATCAATTTTCAAACAACCGGTAACCA AAGTCACAAATCATCCTAGTAATAAAGTGAAATCAGACCCACAACGAATGAATGAACAGCCACGTCAGCTTTTCTGGGAGAAGAGGCTAC AAGGACTTAGTGCATCAGATGTAACAGAACAAATTATAAAAACCATGGAACTACCCAAAGGTCTTCAAGGAGTTGGTCCAGGTAGCAATG ATGAGACCCTTTTATCTGCTGTTGCCAGTGCTTTGCACACAAGCTCTGCGCCAATCACAGGGCAAGTCTCCGCTGCTGTGGAAAAGAACC CTGCTGTTTGGCTTAACACATCTCAACCCCTCTGCAAAGCTTTTATTGTCACAGATGAAGACATCAGGAAACAGGAAGAGCGAGTACAGC AAGTACGCAAGAAATTGGAAGAAGCACTGATGGCAGACATCTTGTCGCGAGCTGCTGATACAGAAGAGATGGATATTGAAATGGACAGTG GAGATGAAGCCTAAGAATATGATCAGGTAACTTTCGACCGACTTTCCCCAAGAGAAAATTCCTAGAAATTGAACAAAAATGTTTCCACTG GCTTTTGCCTGTAAGAAAAAAAATGTACCCGAGCACATAGAGCTTTTTAATAGCACTAACCAATGCCTTTTTAGATGTATTTTTGATGTA TATATCTATTATTCAAAAAATCATGTTTATTTTGAGTCCTAGGACTTAAAATTAGTCTTTTGTAATATCAAGCAGGACCCTAAGATGAAG CTGAGCTTTTGATGCCAGGTGCAATCTACTGGAAATGTAGCACTTACGTAAAACATTTGTTTCCCCCACAGTTTTAATAAGAACAGATCA GGAATTCTAAATAAATTTCCCAGTTAAAGATTATTGTGACTTCACTGTATATAAACATATTTTTATACTTTATTGAAAGGGGACACCTGT ACATTCTTCCATCATCACTGTAAAGACAAATAAATGATTATATTCACAGACTGATTGGAATTCTTTCTGTTGAAAAGCACACACAATAAA GAACCCCTCGTTAGCCTTCCTCTGATTTACATTCAACTCTGATCCCTGGGCCTTAGGTTTGACATGGAGGTGGAGGAAGATAGCGCATAT ATTTGCAGTATGAACTATTGCCTCTGGACGTTGTGAGAATTGTGCTTTCACCAGAATTTCTAAGAATTTCTGCTAAATATCACCTAGCAT GTGTAATTTTTTTTCCTTGCCTGTGACTTGGACTTTTGATAGTTCTATAAGAATAAGGCTTTTTCTTCCCTTGGGCATGAGTCAGATACA CAAGGACCCTTCAGGTGTTACTAGAAGGCGTCCATGTTTATTGTTTTTTAAAGAATGTTTGGCACTCTCTAACGTCCACTAGCTTACTGA GTTATCAGGTGCAGGTCAGACTCTTGGCTACAGTGAGAGGCAGCTTCTAGACAGAGTTGCTTAATGAAAGGGTTTGTAATACTTTACAAA CCATTACCTGTACCTGGCCTGGCCTCCAAAATATTAACATTCTTTTTCTGTTGAAACTCGCGAGTGTAACTTTCATACCACTTGAATTTA TTGATATTTAATTATGAAAACTAGCATTACATTATTAAACGATTTCTAAAATCAAAACATACTTAATCTGATACCAAGGAAGGGAGGGAG TGGTTATAAGCAAATGAAAACAAATTTTGAGAGACAGAGCAAAAGTAAAATCATTCTATAGAAAAGGTGTGTTTATTTCTTAACTCTTGA GTTCTTTTAAAATTAGAACCTAAATGATGCAGTCAGGGGTATGACCAATTCCACATGAGTGTCACCTGTACATTTTATTACCACTACCTC CAGTTTCCAAGGCAGGGAAGAAGAGGGGAATAGTCAAAGCAATATGACTAGCTAGGTTTGGGCTGCTGTTTGGGCTGCTGTTTTTCCTGG ACTTTTATGCCAAACTACATAAATACTTCTTGGAATTCCTGATTTACGCTCAACTTTGATCCCTGGACCCTAGGGCCATTAGTTTCCTTG AAGCAGTCCTGCTGGTGGATGAGCAGGGAAACTTGTAGACCCTGGGAAGCCAATTGGTAGAGGGTGCCTGCCCGCCCCATCAGACTGTCC CAACTGGGGTGGGGGTGAGGATCATAGTGATTTCTTTTTAAAAGCTAGTATGACTAGTGAGAATGGATGTCCAAGGGCTTTTCTCTTCCT CCCCCGAGTCCACGATTCTTCATTTGTGATCAGGGTTGGGGTAACTTCACCTTGGTGATCATATATTCTTTTTACAAACCAATCCAGCCA AGATATATGTGCTTTTCTAAACAGCTTGTAAAAGCAAAAACACAATGTATACACATATAAAACTGATTTTTTTTTTTTTGCTTATATACT TTGCTCAGGTGGAGAACAAGGTATGAAAGCCATTATATGGTGTCCCTTGGGGACCATCCCATAAGTCCAGGGTGTTCCCAATATACCCAC AAGACAACATGTTCAAAACTTCATCACCTGGTCCCCACAAACCTACCACCCTCTTCCATTCCCTCACTCTGGTAAAAGCAAGCCATCTTC TCCAGTTACGCAAGGCAGAAGCCCAGGAGTGAGCACAATGCTGCCCTTTCCCTTGCTTCTGACTTCTCATCAATCCTATTAGAACTACTG ACTGCACCCCACCTCTCCTCCATCCCCACGATCACTGCCTTCATATGAACTGCCTTTCCTGTCCTCTGGACTTTCAGTGGCTTCCTTTTT TGCTCACCTGTCCACTTTCTTCCCCTTCCCTCTCTCCATCCCTCCACATAGTCATCAGAAAGATCATCAAAACAGGCAAATGTGACTGTA TTATTTCCCTCACTTATCTTTGTATGCAGTTTAGAGTGATTTTTAAGAGCACACACTTTGAAATTAGGAGAACCTGTGTCTGAATCCTGA TTTTTGCCATTTGTGTGACTTGTCAGGTTATTTAATCTCTTTGAGCCTGTCCCTCCTCAGTGAAATAGGAATAATAATACCTACCTCATA GAGTTGTTGTGAGGATTCAGTGAGATAGACTGTTTCTAAAGTGTGTAGCACAGTGCCTGGCACATAGTGGGTGCTCACATTGGAGCACAC TATTGTCGCTATCCCTGCA >25669_25669_2_EIF2AK3-MBD2_EIF2AK3_chr2_88913242_ENST00000303236_MBD2_chr18_51715381_ENST00000256429_length(amino acids)=348AA_BP=171 MGAPSGGRGRRQWLRLHACARGGTLMERAISPGLLVRALLLLLLLLGLAARTVAAGRARGLPAPTAEAAFGLGAAAAPTSATRVPAAGAV AAAEVTVEDAEALPAAAGEQEPRGPEPDDETELRPRGRSLVIISTLDGRIAALDPENHGKKQWDLDVGSGSLVSSSLSKPEGKPDLNTTL PIRQTASIFKQPVTKVTNHPSNKVKSDPQRMNEQPRQLFWEKRLQGLSASDVTEQIIKTMELPKGLQGVGPGSNDETLLSAVASALHTSS APITGQVSAAVEKNPAVWLNTSQPLCKAFIVTDEDIRKQEERVQQVRKKLEEALMADILSRAADTEEMDIEMDSGDEA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for EIF2AK3-MBD2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for EIF2AK3-MBD2 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for EIF2AK3-MBD2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | EIF2AK3 | C0432217 | Wolcott-Rallison syndrome | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | EIF2AK3 | C0038220 | Status Epilepticus | 1 | CTD_human |
Hgene | EIF2AK3 | C0038868 | Progressive supranuclear palsy | 1 | CTD_human |
Hgene | EIF2AK3 | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | EIF2AK3 | C0270823 | Petit mal status | 1 | CTD_human |
Hgene | EIF2AK3 | C0311335 | Grand Mal Status Epilepticus | 1 | CTD_human |
Hgene | EIF2AK3 | C0393734 | Complex Partial Status Epilepticus | 1 | CTD_human |
Hgene | EIF2AK3 | C0751522 | Status Epilepticus, Subclinical | 1 | CTD_human |
Hgene | EIF2AK3 | C0751523 | Non-Convulsive Status Epilepticus | 1 | CTD_human |
Hgene | EIF2AK3 | C0751524 | Simple Partial Status Epilepticus | 1 | CTD_human |
Hgene | EIF2AK3 | C4551862 | Ophthalmoplegia, Progressive Supranuclear | 1 | CTD_human |
Hgene | EIF2AK3 | C4551863 | Supranuclear Palsy, Progressive, 1 | 1 | CTD_human |
Tgene | C0033578 | Prostatic Neoplasms | 1 | CTD_human | |
Tgene | C0036341 | Schizophrenia | 1 | PSYGENET | |
Tgene | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human | |
Tgene | C2931456 | Prostate cancer, familial | 1 | CTD_human | |
Tgene | C4722327 | PROSTATE CANCER, HEREDITARY, 1 | 1 | CTD_human |